| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Oosterbaan HP et al. | The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women. | 1995 | Maturitas | pmid:7616870 |
| Cagnacci A et al. | A comparison of the central effects of different progestins used in hormone replacement therapy. | 2004 | Maturitas | pmid:15283939 |
| Lazar F et al. | Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. | 2004 | Maturitas | pmid:15283941 |
| Norman-Taylor JQ et al. | Hormone replacement therapy by the transdermal administration of oestradiol and norethisterone. | 1994 | Maturitas | pmid:8015505 |
| Klehr-Bathmann I and Kuhl H | Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. | 1995 | Maturitas | pmid:7616874 |
| Høvik P et al. | Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms. | 1989 | Maturitas | pmid:2498620 |
| Nordin BE et al. | A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women. | 1980 | Maturitas | pmid:7003315 |
| Cornu C et al. | Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. | 2000 | Maturitas | pmid:11137328 |
| Goudev A et al. | Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. | 2002 | Maturitas | pmid:12270582 |
| Tatsumi H et al. | Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. | 2002 | Maturitas | pmid:12191851 |
| Mueck AO et al. | Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women. | 2002 | Maturitas | pmid:12385856 |
| Christodoulacos G et al. | Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women. | 2002 | Maturitas | pmid:12020983 |
| Norris LA et al. | Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. | 2002 | Maturitas | pmid:12385861 |
| Brynhildsen J and Hammar M | Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. | 2005 | Maturitas | pmid:15780536 |
| Staland B | Absorption of an oestrogen-progestogen preparation. | 1983 | Maturitas | pmid:6633271 |
| Seeger H et al. | In vitro effects of tibolone and its metabolites on human vascular coronary cells. | 2007 | Maturitas | pmid:17572028 |
| Eilertsen AL et al. | The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. | 2005 | Maturitas | pmid:16186073 |
| Silfverstolpe G et al. | Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens. | 1982 | Maturitas | pmid:6811837 |
| Yilmazer M et al. | Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. | 2003 | Maturitas | pmid:14625121 |
| Cengiz B et al. | Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women. | 2003 | Maturitas | pmid:14625127 |
| Haapasaari KM et al. | Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. | 1997 | Maturitas | pmid:9255750 |
| Alfie J et al. | Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate. | 1997 | Maturitas | pmid:9255751 |
| Nerbrand C et al. | Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides. | 2002 | Maturitas | pmid:12020980 |
| Ruan X et al. | The pharmacology of dienogest. | 2012 | Maturitas | pmid:22364708 |
| Christodoulakos G et al. | Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. | 2005 | Maturitas | pmid:15780533 |
| Gruber DM et al. | Endometrial cancer after combined hormone replacement therapy. | 1999 | Maturitas | pmid:10340283 |
| Christodoulakos GE et al. | The effect of low dose hormone therapy on mammographic breast density. | 2006 | Maturitas | pmid:16198519 |
| Modena MG et al. | New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. | 2005 | Maturitas | pmid:15963666 |
| Staland B | Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. | 1981 | Maturitas | pmid:7026979 |
| Fernandes CE et al. | Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. | 2008 | Maturitas | pmid:18359175 |
| Thunell L et al. | The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. | 2006 | Maturitas | pmid:16198072 |
| Odmark IS et al. | Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. | 2004 | Maturitas | pmid:15172088 |
| Albertazzi P et al. | The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. | 2000 | Maturitas | pmid:11063905 |
| Kwok S et al. | Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. | 2006 | Maturitas | pmid:16139447 |
| Zhou J et al. | Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. | 2013 | Maturitas | pmid:23856385 |
| Bassol S et al. | The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women. | 2005 | Maturitas | pmid:15734600 |
| Oguz S et al. | The role of hormone replacement therapy in endometrial polyp formation. | 2005 | Maturitas | pmid:15734604 |
| al-Azzawi F et al. | Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50. | 1994 | Maturitas | pmid:8177092 |
| Posaci C et al. | Effects of HRT on serum levels of IGF-I in postmenopausal women. | 2001 | Maturitas | pmid:11684375 |
| Eilertsen AL et al. | Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. | 2006 | Maturitas | pmid:16713143 |
| Paterson ME | A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters. | 1982 | Maturitas | pmid:6750325 |
| Stadberg E et al. | 17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. | 1996 | Maturitas | pmid:8861084 |
| Lindgren R et al. | Endometrial effects of transdermal estradiol/norethisterone acetate. | 1992 | Maturitas | pmid:1528133 |
| Byrjalsen I et al. | Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status. | 1990 | Maturitas | pmid:2255265 |
| Saarikoski S et al. | Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders. | 1990 | Maturitas | pmid:2255266 |
| Mattsson LA et al. | Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. | 1982 | Maturitas | pmid:7121296 |
| Schindler AE et al. | Classification and pharmacology of progestins. | 2003 | Maturitas | pmid:14670641 |
| Jondet M and Dehennin L | Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study. | 2003 | Maturitas | pmid:14585519 |
| Pata O et al. | The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. | 2003 | Maturitas | pmid:14585524 |
| Christodoulakos GE et al. | The effect of various regimens of hormone replacement therapy on mammographic breast density. | 2003 | Maturitas | pmid:12787969 |